P2RY12 and acute coronary syndrome: Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is the standard of care for the prevention of recurrent atherothrombotic events in patients with an acute coronary syndrome (ACS) [1].